A federal judge in Maine has put the brakes on a pilot program that would have enabled biopharma companies to offer rebates instead of discounts as part of the 340B program beginning Jan. 1, 2026.

The BioMarin Pharmaceutical Inc. acquisition of Amicus Therapeutics, Inc. will likely be beneficial and accretive for both ...

The Rewa Model Farm Project marked a significant milestone for the advancement of Natural Farming in Madhya Pradesh with its ...

This study presents SynaptoGen, a differentiable extension of connectome models that links gene expression, protein-protein interaction probabilities, synaptic multiplicity, and synaptic weights, and ...

Artificial intelligence is making waves with crypto predictions as the year wraps up. We ran a real-time accuracy test to see ...

Download the latest Karnataka 2nd PUC Biology Model Question Paper 2025–26 with answers. Master the DPUE blueprint, marking ...

Tennis legend Venus Williams and actor Andrea Preti are officially husband and wife. The multi-Grand Slam champion has been ...

Digital avatar generation company Lemon Slice is working to add a video layer to AI chatbots with a new diffusion model that ...

BioMarin Pharmaceutical’s strong rare disease drug portfolio and Amicus acquisition drive a ‘Buy’ rating. Click here to read my latest analysis of BMRN stock.

Julie Sariñana, also known as Sincerely Jules, is a Mexican-American fashion influencer, blogger, model, and entrepreneur ...

Jimmy Wales discusses Wikipedia's core values, the vital role of its volunteer community, and why the platform is not for sale ...

Skincare brand Bio-Xin Cosmeceuticals has officially launched its flagship service, the “Bio-Xin Derma Scan AI Skin Analyzer.